Healthcare
Doximity, Inc.(DOCS)
Live Price
Offline$20.46
+0.05% today
1Y Change
-66.00%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $4.84B
- Revenue Growth
- +20.0%
- EPS Growth
- +52.6%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Doximity, Inc. (DOCS) is a Healthcare stock with a market cap of $4.84B and listed on NYSE. The stock last traded around $20.46 and down 66.0% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +20.0%, EPS growth of +52.6%, a dividend yield of 0.0%. What stands out right now is revenue +20.0%, EPS +52.6%, free cash flow +49.6% with operating margin 37.4% and ROIC 20.5%. Valuation sits in the middle of the pack at P/E 20.2 and price/sales 7.6. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines DOCS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+20.0% vs +7.6% peer median
Operating Margin
Above sector median
+37.4% vs +19.4% peer median
P/E
Below sector median
20.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 21, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +20.0% and EPS at +52.6%, with operating margin around 37.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -12.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 21, 2026 | โ | +2.8% | +10.4% | โ |
2026 Feb 5, 2026 | +4.5% | -16.8% | -25.8% | -23.9% |
2025 Nov 6, 2025 | +18.8% | -13.2% | -20.5% | -26.6% |
Benchmark Edge
DOCS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DOCS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DOCS Max Drawdown
-76.03%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DOCS and SPY.
Company Overview
Doximity, Inc.
New York Stock Exchange
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
- Leadership
- Jeffrey A. Tangney
- IPO Date
- Jun 24, 2021
- Employees
- 827
- Street Address
- 500, 3rd Street
- Mailing
- San Francisco, CA, 94107
- Region
- San Francisco, CA, US
- Reporting Currency
- USD
- Investor Line
- 650 549 4330
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 20.2
- EV/EBITDA
- 17.6
- Price/Sales
- 7.6
- Price/Book
- 4.9
Growth
- Revenue
- +20.0%
- EPS
- +52.6%
- Free Cash Flow
- +49.6%
Profitability
- Gross Margin
- 89.7%
- Operating Margin
- 37.4%
- Net Margin
- 37.5%
- ROE
- 22.9%
- ROIC
- 20.5%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 6.63
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.